NasdaqGM:MRUSBiotechs
The Bull Case For Merus (MRUS) Could Change Following Surging Revenue and Escalating Losses in Q2 2025
Merus N.V. recently reported its second quarter and six-month 2025 earnings, showing revenue growth to US$8.83 million and US$35.32 million respectively, while net losses widened to US$158.22 million for the quarter and US$254.69 million for the half-year compared to the previous year.
The substantial year-on-year increase in revenue was accompanied by a much larger rise in net loss, spotlighting the company's resource allocation and expense trajectory amid ongoing development efforts.
We'll...